CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $313,000 | +58.9% | 155,020 | +112.7% | 0.00% | +100.0% |
| Q4 2021 | $197,000 | -45.0% | 72,868 | -9.1% | 0.00% | -60.0% |
| Q3 2021 | $358,000 | -47.7% | 80,202 | -32.1% | 0.01% | -37.5% |
| Q2 2021 | $685,000 | +254.9% | 118,079 | +256.0% | 0.01% | +100.0% |
| Q3 2020 | $193,000 | -25.8% | 33,169 | -14.0% | 0.00% | -42.9% |
| Q2 2020 | $260,000 | +101.6% | 38,562 | +210.6% | 0.01% | +250.0% |
| Q4 2019 | $129,000 | – | 12,415 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |